{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T16:22:30Z","timestamp":1794759750961,"version":"4.9.1"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Airway mucus is a highly specialised secretory fluid which functions as a physical and immunological barrier to pathogens whilst lubricating the airways and humifying atmospheric air. Dysfunction is common during critical illness and is characterised by changes in production rate, chemical composition, physical properties, and inflammatory phenotype. Mucociliary clearance, which is determined in part by mucus characteristics and in part by ciliary function, is also dysfunctional in critical illness via disease related and iatrogenic mechanisms. The consequences of mucus dysfunction are potentially devastating, contributing to prolonged ventilator dependency, increased risk of secondary pneumonia, and worsened lung injury. Mucolytic therapies are designed to decrease viscosity, improve expectoration\/suctioning, and thereby promote mucus removal. Mucolytics, including hypertonic saline, dornase alfa\/rhDNase, nebulised heparin, carbocisteine\/N-Acetyl cysteine, are commonly used in critically ill patients. This review summarises the physiology and pathophysiology of mucus and the existing evidence for the use of mucolytics in critically ill patients and speculates on journey to individualised mucolytic therapy.<\/jats:p>","DOI":"10.1186\/s13054-025-05286-x","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:52:11Z","timestamp":1738918331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Physiology and pathophysiology of mucus and mucolytic use in critically ill patients"],"prefix":"10.1186","volume":"29","author":[{"given":"Thomas","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Terrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Johal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kordo","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cusack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P. W.","family":"Grocott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahilanandan","family":"Dushianthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"15","key":"5286_CR1","doi-asserted-by":"publisher","first-page":"R938","DOI":"10.1016\/j.cub.2021.06.093","volume":"31","author":"A McShane","year":"2021","unstructured":"McShane A, Bath J, Jaramillo AM, Ridley C, Walsh AA, Evans CM, et al. Mucus. Curr Biol. 2021;31(15):R938\u201345.","journal-title":"Curr Biol"},{"key":"5286_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","volume":"124","author":"R Bansil","year":"2018","unstructured":"Bansil R, Turner BS. The biology of mucus: Composition, synthesis and organization. Adv Drug Deliv Rev. 2018;124:3\u201315.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"5286_CR3","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1084\/jem.20180610","volume":"216","author":"L Campbell","year":"2019","unstructured":"Campbell L, Hepworth MR, Whittingham-Dowd J, Thompson S, Bancroft AJ, Hayes KS, et al. ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. J Exp Med. 2019;216(12):2714\u201323.","journal-title":"J Exp Med"},{"issue":"12","key":"5286_CR4","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41564-019-0581-8","volume":"4","author":"KM Wheeler","year":"2019","unstructured":"Wheeler KM, C\u00e1rcamo-Oyarce G, Turner BS, Dellos-Nolan S, Co JY, Lehoux S, et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection. Nat Microbiol. 2019;4(12):2146\u201354.","journal-title":"Nat Microbiol"},{"key":"5286_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.copbio.2018.03.010","volume":"52","author":"J Witten","year":"2018","unstructured":"Witten J, Samad T, Ribbeck K. Selective permeability of mucus barriers. Curr Opin Biotechnol. 2018;52:124\u201333.","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"5286_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1378\/chest.08-0412","volume":"135","author":"JA Voynow","year":"2009","unstructured":"Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135(2):505\u201312.","journal-title":"Chest"},{"issue":"1","key":"5286_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MCP.0b013e32831da8d3","volume":"15","author":"CM Evans","year":"2009","unstructured":"Evans CM, Kim K, Tuvim MJ, Dickey BF. Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med. 2009;15(1):4\u201311.","journal-title":"Curr Opin Pulm Med"},{"key":"5286_CR8","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S38938","author":"F Ramos","year":"2014","unstructured":"Ramos F, Krahnke J, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis. 2014. https:\/\/doi.org\/10.2147\/COPD.S38938.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"5286_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24530","author":"CB Morrison","year":"2019","unstructured":"Morrison CB, Markovetz MR, Ehre C. Mucus, mucins, and cystic fibrosis. Pediatric Pulmonology. 2019. https:\/\/doi.org\/10.1002\/ppul.24530.","journal-title":"Pediatric Pulmonology"},{"issue":"7","key":"5286_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5483\/BMBRep.2021.54.7.064","volume":"54","author":"DH Wi","year":"2021","unstructured":"Wi DH, Cha JH, Jung YS. Mucin in cancer: a stealth cloak for cancer cells. BMB Rep. 2021;54(7):344\u201355.","journal-title":"BMB Rep"},{"key":"5286_CR11","first-page":"13","volume":"23","author":"RL Goetz","year":"2022","unstructured":"Goetz RL, Vijaykumar K, Solomon GM. Mucus clearance strategies in mechanically ventilated patients. Front Physiol. 2022;23:13.","journal-title":"Front Physiol"},{"issue":"6","key":"5286_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1378\/chest.68.6.774","volume":"68","author":"MA Sackner","year":"1975","unstructured":"Sackner MA, Hirsch J, Epstein S. Effect of cuffed endotracheal tubes on tracheal mucous velocity. Chest. 1975;68(6):774\u20137.","journal-title":"Chest"},{"issue":"1","key":"5286_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/0003-4819-82-1-40","volume":"82","author":"MA Sackner","year":"1975","unstructured":"Sackner MA. Pulmonary effects of oxygen breathing. Ann Intern Med. 1975;82(1):40.","journal-title":"Ann Intern Med"},{"issue":"1","key":"5286_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1378\/chest.124.1.262","volume":"124","author":"M Smina","year":"2003","unstructured":"Smina M, Salam A, Khamiees M, Gada P, Amoateng-Adjepong Y, Manthous CA. Cough peak flows and extubation outcomes. Chest. 2003;124(1):262\u20138.","journal-title":"Chest"},{"issue":"2","key":"5286_CR15","first-page":"58","volume":"45","author":"D Oberbeck","year":"1993","unstructured":"Oberbeck D, Janssen W, Petersen C. Death in bronchial asthma. Findings and forensic importance. Versicherungsmedizin. 1993;45(2):58\u201363.","journal-title":"Versicherungsmedizin."},{"issue":"8","key":"5286_CR16","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.62347\/AUIB5552","volume":"16","author":"L Li","year":"2024","unstructured":"Li L. Comprehensive airway management of ventilator-associated pneumonia in ICU populations. Am J Transl Res. 2024;16(8):4225\u201333.","journal-title":"Am J Transl Res"},{"issue":"8","key":"5286_CR17","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8828","volume":"4","author":"M Borthwick","year":"2020","unstructured":"Borthwick M, McAuley D, Warburton J, Anand R, Bradley J, Connolly B, et al. Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals\u2019 perception, pharmacists\u2019 description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients. PeerJ. 2020;4(8): e8828.","journal-title":"PeerJ"},{"issue":"10","key":"5286_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/17476348.2017.1359090","volume":"11","author":"BL Icard","year":"2017","unstructured":"Icard BL, Rubio E. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature. Expert Rev Respir Med. 2017;11(10):807\u201314.","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"5286_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4187\/respcare.04165","volume":"60","author":"SL Strickland","year":"2015","unstructured":"Strickland SL, Rubin BK, Haas CF, Volsko TA, Drescher GS, O\u2019Malley CA. AARC clinical practice guideline: effectiveness of pharmacologic airway clearance therapies in hospitalized patients. Respir Care. 2015;60(7):1071\u20137.","journal-title":"Respir Care"},{"issue":"8","key":"5286_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/thoraxjnl-2019-214355","volume":"75","author":"R Anand","year":"2020","unstructured":"Anand R, McAuley DF, Blackwood B, Yap C, ONeill B, Connolly B, et al. Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis. Thorax. 2020;75(8):623\u201331.","journal-title":"Thorax"},{"issue":"11","key":"5286_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/thx.39.11.844","volume":"39","author":"AB Lumsden","year":"1984","unstructured":"Lumsden AB, McLean A, Lamb D. Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax. 1984;39(11):844\u20139.","journal-title":"Thorax"},{"key":"5286_CR22","unstructured":"Tos M. Development of the tracheal glands in man. Number, density, structure, shape, and distribution of mucous glands elucidated by quantitative studies of whole mounts. Acta Pathol Microbiol Scand. 1966;68:Suppl 185:3+."},{"issue":"2","key":"5286_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1469-7580.2001.19820207.x","volume":"198","author":"JH Widdicombe","year":"2001","unstructured":"Widdicombe JH, Chen LL, Sporor H, Choi HK, Pecson IS, Bastacky SJ. Distribution of tracheal and laryngeal mucous glands in some rodents and the rabbit. J Anat. 2001;198(2):207\u201321.","journal-title":"J Anat"},{"issue":"1","key":"5286_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/aja.1001840104","volume":"184","author":"CG Plopper","year":"1989","unstructured":"Plopper CG, Heidsiek JG, Weir AJ, St. George JA, Hyde DM. Tracheobronchial epithelium in the adult rhesus monkey: a quantitative histochemical and ultrastructural study. Am J Anatomy. 1989;184(1):31\u201340.","journal-title":"Am J Anatomy"},{"issue":"1","key":"5286_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/oxfordjournals.bmb.a071454","volume":"34","author":"JM Creeth","year":"1978","unstructured":"Creeth JM. Constituents of mucus and their separation. Br Med Bull. 1978;34(1):17\u201324.","journal-title":"Br Med Bull"},{"key":"5286_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-physiol-021909-135909","volume":"72","author":"SE Evans","year":"2010","unstructured":"Evans SE, Xu Y, Tuvim MJ, Dickey BF. Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol. 2010;72:413\u201335.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"5286_CR27","doi-asserted-by":"publisher","first-page":"L92","DOI":"10.1152\/ajplung.90388.2008","volume":"296","author":"M Kesimer","year":"2009","unstructured":"Kesimer M, Kirkham S, Pickles RJ, Henderson AG, Alexis NE, Demaria G, et al. Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol. 2009;296(1):L92-100.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5286_CR28","first-page":"7","volume":"22","author":"S Pinz\u00f3n Mart\u00edn","year":"2019","unstructured":"Pinz\u00f3n Mart\u00edn S, Seeberger PH, Var\u00f3n SD. Mucins and pathogenic mucin-like molecules are immunomodulators during infection and targets for diagnostics and vaccines. Front Chem. 2019;22:7.","journal-title":"Front Chem"},{"issue":"2","key":"5286_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang YY, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Adv Drug Deliv Rev. 2009;61(2):86\u2013100.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"5286_CR30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/glycob\/cwt045","volume":"23","author":"KSB Bergstrom","year":"2013","unstructured":"Bergstrom KSB, Xia L. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology. 2013;23(9):1026\u201337.","journal-title":"Glycobiology"},{"issue":"4","key":"5286_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/mi.2015.32","volume":"8","author":"GMH Birchenough","year":"2015","unstructured":"Birchenough GMH, Johansson ME, Gustafsson JK, Bergstr\u00f6m JH, Hansson GC. New developments in goblet cell mucus secretion and function. Mucosal Immunol. 2015;8(4):712\u20139.","journal-title":"Mucosal Immunol"},{"key":"5286_CR32","first-page":"10","volume":"9","author":"MC Bond","year":"2021","unstructured":"Bond MC, Vidakovic L, Singh PK, Drescher K, Nadell CD. Matrix-trapped viruses can prevent invasion of bacterial biofilms by colonizing cells. Elife. 2021;9:10.","journal-title":"Elife"},{"key":"5286_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01984-19","author":"GMF Almeida","year":"2019","unstructured":"Almeida GMF, Laanto E, Ashrafi R, Sundberg LR. Bacteriophage adherence to mucus mediates preventive protection against pathogenic bacteria. mBio. 2019. https:\/\/doi.org\/10.1128\/mBio.01984-19.","journal-title":"mBio"},{"issue":"2","key":"5286_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/jmv.26406","volume":"93","author":"W Lu","year":"2021","unstructured":"Lu W, Liu X, Wang T, Liu F, Zhu A, Lin Y, et al. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients. J Med Virol. 2021;93(2):582\u20134.","journal-title":"J Med Virol"},{"issue":"1","key":"5286_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","volume":"70","author":"DJ Thornton","year":"2008","unstructured":"Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70(1):459\u201386.","journal-title":"Annu Rev Physiol"},{"issue":"23","key":"5286_CR36","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233\u201347.","journal-title":"N Engl J Med"},{"issue":"5","key":"5286_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI0215217","volume":"109","author":"MR Knowles","year":"2002","unstructured":"Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109(5):571\u20137.","journal-title":"J Clin Invest"},{"issue":"1","key":"5286_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1513\/pats.2306016","volume":"1","author":"DJ Thornton","year":"2004","unstructured":"Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc. 2004;1(1):54\u201361.","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"5286_CR39","doi-asserted-by":"publisher","first-page":"L15","DOI":"10.1152\/ajplung.00194.2009","volume":"298","author":"M Kesimer","year":"2010","unstructured":"Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol. 2010;298(1):L15-22.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5286_CR40","unstructured":"Rogers DF. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care. 2007;52(9):1134\u201346; discussion 1146\u20139."},{"issue":"2","key":"5286_CR41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4049\/jimmunol.1002257","volume":"187","author":"T Oguma","year":"2011","unstructured":"Oguma T, Asano K, Tomomatsu K, Kodama M, Fukunaga K, Shiomi T, et al. Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J Immunol. 2011;187(2):999\u20131005.","journal-title":"J Immunol"},{"issue":"3","key":"5286_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1165\/rcmb.2005-0460OC","volume":"37","author":"HWJ Young","year":"2007","unstructured":"Young HWJ, Williams OW, Chandra D, Bellinghausen LK, P\u00e9rez G, Su\u00e1rez A, et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5\u2032 elements. Am J Respir Cell Mol Biol. 2007;37(3):273\u201390.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"5286_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S2213-2600(21)00079-5","volume":"9","author":"G Radicioni","year":"2021","unstructured":"Radicioni G, Ceppe A, Ford AA, Alexis NE, Barr RG, Bleecker ER, et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2021;9(11):1241\u201354.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"5286_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.202008-3198OC","volume":"203","author":"K Okuda","year":"2021","unstructured":"Okuda K, Dang H, Kobayashi Y, Carraro G, Nakano S, Chen G, et al. Secretory cells dominate airway CFTR expression and function in human airway superficial epithelia. Am J Respir Crit Care Med. 2021;203(10):1275\u201389.","journal-title":"Am J Respir Crit Care Med"},{"key":"5286_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003755","author":"B Button","year":"2013","unstructured":"Button B, Okada SF, Frederick CB, Thelin WR, Boucher RC. Mechanosensitive ATP release maintains proper mucus hydration of airways. Sci Signal. 2013. https:\/\/doi.org\/10.1126\/scisignal.2003755.","journal-title":"Sci Signal"},{"issue":"6097","key":"5286_CR46","first-page":"937","volume":"337","author":"B Button","year":"2012","unstructured":"Button B, Cai LH, Ehre C, Kesimer M, Hill DB, Sheehan JK, et al. A Periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 1979. 2012;337(6097):937\u201341.","journal-title":"Science 1979"},{"issue":"4","key":"5286_CR47","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1152\/physrev.00004.2021","volume":"102","author":"DB Hill","year":"2022","unstructured":"Hill DB, Button B, Rubinstein M, Boucher RC. Physiology and pathophysiology of human airway mucus. Physiol Rev. 2022;102(4):1757\u2013836.","journal-title":"Physiol Rev"},{"key":"5286_CR48","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20130109","author":"J Tong","year":"2014","unstructured":"Tong J, Zhou XD, Perelman JM, Kolosov VP. Effect of epithelium ATP release on cyclic pressure-induced airway mucus secretion. 2014. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20130109."},{"key":"5286_CR49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev.physiol.68.072304.112754","volume":"68","author":"R Tarran","year":"2006","unstructured":"Tarran R, Button B, Boucher RC. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol. 2006;68:543\u201361.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"5286_CR50","doi-asserted-by":"publisher","first-page":"L258","DOI":"10.1152\/ajplung.1998.274.2.L258","volume":"274","author":"L Trout","year":"1998","unstructured":"Trout L, King M, Feng W, Inglis SK, Ballard ST. Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus. Am J Physiology-Lung Cellular Mol Physiol. 1998;274(2):L258\u201363.","journal-title":"Am J Physiology-Lung Cellular Mol Physiol"},{"issue":"7","key":"5286_CR51","first-page":"761","volume":"47","author":"BK Rubin","year":"2002","unstructured":"Rubin BK. Physiology of airway mucus clearance. Respir Care. 2002;47(7):761\u20138.","journal-title":"Respir Care"},{"issue":"Supplement_3","key":"5286_CR52","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1513\/AnnalsATS.201802-128AW","volume":"15","author":"JA Whitsett","year":"2018","unstructured":"Whitsett JA. Airway Epithelial Differentiation and Mucociliary Clearance. Ann Am Thorac Soc. 2018;15(Supplement_3):S143\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.201802-128AW.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"5286_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028241","volume":"9","author":"XM Bustamante-Marin","year":"2017","unstructured":"Bustamante-Marin XM, Ostrowski LE. Cilia and Mucociliary Clearance. Cold Spring Harb Perspect Biol. 2017;9(4): a028241.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"5286_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev.physiol.69.040705.141253","volume":"69","author":"M Salathe","year":"2007","unstructured":"Salathe M. Regulation of mammalian ciliary beating. Annu Rev Physiol. 2007;69(1):401\u201322.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"5286_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1242\/jcs.066308","volume":"123","author":"RA Bloodgood","year":"2010","unstructured":"Bloodgood RA. Sensory reception is an attribute of both primary cilia and motile cilia. J Cell Sci. 2010;123(4):505\u20139.","journal-title":"J Cell Sci"},{"issue":"1","key":"5286_CR56","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1038\/s41598-020-64695-w","volume":"10","author":"S Gsell","year":"2020","unstructured":"Gsell S, Loiseau E, D\u2019Ortona U, Viallat A, Favier J. Hydrodynamic model of directional ciliary-beat organization in human airways. Sci Rep. 2020;10(1):8405.","journal-title":"Sci Rep"},{"key":"5286_CR57","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1513\/AnnalsATS.201804-238AW","volume":"15","author":"A Ermund","year":"2018","unstructured":"Ermund A, Trillo-Muyo S, Hansson GC. Assembly, release, and transport of airway mucins in pigs and humans. Ann Am Thorac Soc. 2018;15:S159-63.","journal-title":"Ann Am Thorac Soc"},{"key":"5286_CR58","doi-asserted-by":"crossref","unstructured":"Roth D, \u015eahin AT, Ling F, Senger CN, Quiroz EJ, Calvert BA, et al. Structure-function relationships of mucociliary clearance in human airways. bioRxiv. 2024 Mar 22;","DOI":"10.1101\/2023.12.24.572054"},{"issue":"1","key":"5286_CR59","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1038\/s41598-019-54292-x","volume":"9","author":"S Gohy","year":"2019","unstructured":"Gohy S, Carlier FM, Fregimilicka C, Detry B, Lecocq M, Ladjemi MZ, et al. Altered generation of ciliated cells in chronic obstructive pulmonary disease. Sci Rep. 2019;9(1):17963.","journal-title":"Sci Rep"},{"issue":"2","key":"5286_CR60","doi-asserted-by":"publisher","first-page":"2003393","DOI":"10.1183\/13993003.03393-2020","volume":"58","author":"WW Busse","year":"2021","unstructured":"Busse WW, Kraft M, Rabe KF, Deniz Y, Rowe PJ, Ruddy M, et al. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J. 2021;58(2):2003393.","journal-title":"Eur Respir J"},{"issue":"3","key":"5286_CR61","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1152\/jappl.1987.62.3.959","volume":"62","author":"CS Kim","year":"1987","unstructured":"Kim CS, Iglesias AJ, Sackner MA. Mucus clearance by two-phase gas-liquid flow mechanism: asymmetric periodic flow model. J Appl Physiol. 1987;62(3):959\u201371.","journal-title":"J Appl Physiol"},{"issue":"9","key":"5286_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023914","volume":"6","author":"J Villar","year":"2011","unstructured":"Villar J, Cabrera NE, Valladares F, Casula M, Flores C, Blanch L, et al. Activation of the Wnt\/\u03b2-Catenin signaling pathway by mechanical ventilation is associated with ventilator-induced pulmonary fibrosis in healthy lungs. PLoS ONE. 2011;6(9): e23914.","journal-title":"PLoS ONE"},{"issue":"2","key":"5286_CR63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1152\/jappl.1989.67.2.614","volume":"67","author":"L Freitag","year":"1989","unstructured":"Freitag L, Long WM, Kim CS, Wanner A. Removal of excessive bronchial secretions by asymmetric high-frequency oscillations. J Appl Physiol. 1989;67(2):614\u20139.","journal-title":"J Appl Physiol"},{"issue":"1","key":"5286_CR64","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13054-024-05127-3","volume":"28","author":"L Gerard","year":"2024","unstructured":"Gerard L, Lecocq M, Detry B, Bouzin C, Hoton D, Pinto Pereira J, et al. Airway epithelium damage in acute respiratory distress syndrome. Crit Care. 2024;28(1):350.","journal-title":"Crit Care"},{"issue":"3","key":"5286_CR65","doi-asserted-by":"publisher","first-page":"L325","DOI":"10.1152\/ajplung.00522.2021","volume":"324","author":"D Teape","year":"2023","unstructured":"Teape D, Peterson A, Ahsan N, Ellis K, Correia N, Luo R, et al. Hyperoxia impairs intraflagellar transport and causes dysregulated metabolism with resultant decreased cilia length. Am J Physiology-Lung Cellular Mol Physiol. 2023;324(3):L325\u201334.","journal-title":"Am J Physiology-Lung Cellular Mol Physiol"},{"issue":"10","key":"5286_CR66","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.4049\/jimmunol.0900614","volume":"183","author":"T Fujisawa","year":"2009","unstructured":"Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R. Regulation of airway MUC5AC Expression by IL-1\u03b2 and IL-17A; the NF-\u03baB Paradigm. J Immunol. 2009;183(10):6236\u201343.","journal-title":"J Immunol"},{"issue":"4","key":"5286_CR67","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1378\/chest.128.4.2772","volume":"128","author":"NK Nakagawa","year":"2005","unstructured":"Nakagawa NK, Franchini ML, Driusso P, de Oliveira LR, Saldiva PHN, Lorenzi-Filho G. Mucociliary clearance is impaired in acutely Ill patients. Chest. 2005;128(4):2772\u20137.","journal-title":"Chest"},{"issue":"4","key":"5286_CR68","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/mi.2012.114","volume":"6","author":"M Koeppen","year":"2013","unstructured":"Koeppen M, McNamee EN, Brodsky KS, Aherne CM, Faigle M, Downey GP, et al. Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury. Mucosal Immunol. 2013;6(4):762\u201375.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"5286_CR69","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1164\/ajrccm.163.2.2004039","volume":"163","author":"CL Ordo\u00f1ez","year":"2001","unstructured":"Ordo\u00f1ez CL, Khashayar R, Wong HH, Ferrando R, Wu R, Hyde DM, et al. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med. 2001;163(2):517\u201323.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5286_CR70","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.pupt.2011.12.003","volume":"25","author":"KC Kim","year":"2012","unstructured":"Kim KC. Role of epithelial mucins during airway infection. Pulm Pharmacol Ther. 2012;25(6):415\u20139.","journal-title":"Pulm Pharmacol Ther"},{"key":"5286_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104201","author":"W Khan","year":"2022","unstructured":"Khan W, Safi A, Muneeb M, Mooghal M, Aftab A, Ahmed J. Complications of invasive mechanical ventilation in critically Ill Covid-19 patients\u2014A narrative review. Ann Med Surg. 2022. https:\/\/doi.org\/10.1016\/j.amsu.2022.104201.","journal-title":"Ann Med Surg"},{"issue":"2","key":"5286_CR72","first-page":"95","volume":"10","author":"MS Adivitiya Kaushik","year":"2021","unstructured":"Adivitiya Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary respiratory epithelium integrity in molecular defense and susceptibility to pulmonary viral infections. Biology (Basel). 2021;10(2):95.","journal-title":"Biology (Basel)"},{"issue":"8","key":"5286_CR73","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523\u201334.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"5286_CR74","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1164\/rccm.201709-1819OC","volume":"198","author":"J Powell","year":"2018","unstructured":"Powell J, Garnett JP, Mather MW, Cooles FAH, Nelson A, Verdon B, et al. Excess mucin impairs subglottic epithelial host defense in mechanically ventilated patients. Am J Respir Crit Care Med. 2018;198(3):340\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"5286_CR75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1365-2273.1998.00141.x","volume":"23","author":"A Smallman Pahor","year":"1998","unstructured":"Smallman Pahor A. Age, smoking and nasal ciliary beat frequency. Clin Otolaryngol Allied Sci. 1998;23(3):227\u201330.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"9","key":"5286_CR76","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cells11091416","volume":"11","author":"ME Love","year":"2022","unstructured":"Love ME, Proud D. Respiratory viral and bacterial exacerbations of COPD\u2014the role of the airway epithelium. Cells. 2022;11(9):1416.","journal-title":"Cells"},{"issue":"1","key":"5286_CR77","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13054-015-0996-4","volume":"19","author":"HJF Helmerhorst","year":"2015","unstructured":"Helmerhorst HJF, Schultz MJ, van der Voort PHJ, de Jonge E, van Westerloo DJ. Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care. 2015;19(1):284.","journal-title":"Crit Care"},{"issue":"2","key":"5286_CR78","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1164\/ajrccm\/137.2.450","volume":"137","author":"RMKW Lee","year":"1988","unstructured":"Lee RMKW, O\u2019Brodovich H. Airway epithelial damage in premature infants with respiratory failure. Am Rev Respir Dis. 1988;137(2):450\u20137.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"5286_CR79","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1378\/chest.69.2.164","volume":"69","author":"MA Sackner","year":"1976","unstructured":"Sackner MA, Hirsch JA, Epstein S, Rywlin AM. Effect of oxygen in graded concentrations upon tracheal mucous velocity. Chest. 1976;69(2):164\u20137.","journal-title":"Chest"},{"issue":"3","key":"5286_CR80","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1165\/rcmb.2002-0156OC","volume":"28","author":"X Zhang","year":"2003","unstructured":"Zhang X, Shan P, Sasidhar M, Chupp GL, Flavell RA, Choi AMK, et al. Reactive oxygen species and extracellular signal-regulated Kinase 1\/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. Am J Respir Cell Mol Biol. 2003;28(3):305\u201315.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 2","key":"5286_CR81","first-page":"S177","volume":"13","author":"MA Mall","year":"2016","unstructured":"Mall MA. Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(Suppl 2):S177\u201385.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"5286_CR82","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/cells11050812","volume":"11","author":"J Charriot","year":"2022","unstructured":"Charriot J, Volpato M, Petit A, Vachier I, Bourdin A. Methods of sputum and mucus assessment for muco-obstructive lung diseases in 2022: time to \u201cUnplug\u201d from our daily routine! Cells. 2022;11(5):812.","journal-title":"Cells"},{"issue":"4","key":"5286_CR83","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1165\/rcmb.2003-0211OC","volume":"31","author":"PA Kemp","year":"2004","unstructured":"Kemp PA, Sugar RA, Jackson AD. Nucleotide-mediated mucin secretion from differentiated human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2004;31(4):446\u201355.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"5286_CR84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12931-019-1239-z","volume":"20","author":"KR Atanasova","year":"2019","unstructured":"Atanasova KR, Reznikov LR. Strategies for measuring airway mucus and mucins. Respir Res. 2019;20(1):261.","journal-title":"Respir Res"},{"issue":"4","key":"5286_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1183\/20734735.042912","volume":"9","author":"Z Weiszhar","year":"2013","unstructured":"Weiszhar Z, Horvath I. Induced sputum analysis: step by step. Breathe. 2013;9(4):300\u20136.","journal-title":"Breathe"},{"issue":"11","key":"5286_CR86","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/thx.53.11.953","volume":"53","author":"A Bhowmik","year":"1998","unstructured":"Bhowmik A, Seemungal TAR, Sapsford RJ, Devalia JL, Wedzicha JA. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1998;53(11):953\u20136.","journal-title":"Thorax"},{"issue":"2","key":"5286_CR87","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4187\/respcare.09548","volume":"67","author":"TC Blakeman","year":"2022","unstructured":"Blakeman TC, Scott JB, Yoder MA, Capellari E, Strickland SL. AARC clinical practice guidelines: artificial airway suctioning. Respir Care. 2022;67(2):258\u201371.","journal-title":"Respir Care"},{"issue":"Suppl 1","key":"5286_CR88","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","volume":"68","author":"IA Du Rand","year":"2013","unstructured":"Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British thoracic society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68(Suppl 1):i1-44.","journal-title":"Thorax"},{"issue":"5","key":"5286_CR89","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1440-1843.2011.02001.x","volume":"16","author":"K Looi","year":"2011","unstructured":"Looi K, Sutano EN, Banerjee B, Garratt L, Ling KM, Foo CJ, et al. Bronchial brushings for investigating airway inflammation and remodelling. Respirology. 2011;16(5):725\u201337.","journal-title":"Respirology"},{"issue":"3","key":"5286_CR90","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/ALN.0b013e31826687d5","volume":"117","author":"MF Serra","year":"2012","unstructured":"Serra MF, Anjos-Valotta EA, Olsen PC, Couto GC, Jurgilas PB, Cotias AC, et al. Nebulized lidocaine prevents airway inflammation, peribronchial fibrosis, and mucus production in a murine model of asthma. Anesthesiology. 2012;117(3):580\u201391.","journal-title":"Anesthesiology"},{"issue":"12","key":"5286_CR91","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1080\/00016480510012381","volume":"125","author":"CH Kim","year":"2005","unstructured":"Kim CH, Hyun Song M, Eun Ahn Y, Lee JG, Yoon JH. Effect of hypo-, iso- and hypertonic saline irrigation on secretory mucins and morphology of cultured human nasal epithelial cells. Acta Otolaryngol. 2005;125(12):1296\u2013300.","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"5286_CR92","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1113\/jphysiol.1996.sp021515","volume":"494","author":"SI Ramnarine","year":"1996","unstructured":"Ramnarine SI, Haddad EB, Khawaja AM, Mak JC, Rogers DF. On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol. 1996;494(2):577\u201386.","journal-title":"J Physiol"},{"issue":"10","key":"5286_CR93","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.3390\/ijms19103256","volume":"19","author":"L Terranova","year":"2018","unstructured":"Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, et al. How to process sputum samples and extract bacterial DNA for microbiota analysis. Int J Mol Sci. 2018;19(10):3256.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5286_CR94","doi-asserted-by":"publisher","first-page":"19803","DOI":"10.1038\/s41598-021-99262-4","volume":"11","author":"R Stamatiou","year":"2021","unstructured":"Stamatiou R, Tsolaki V, Hatziefthimiou A, Zakynthinos E, Makris D. Evaluation of airway inflammation in mechanically ventilated patients using cell count and protein concentration. Sci Rep. 2021;11(1):19803.","journal-title":"Sci Rep"},{"issue":"2","key":"5286_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087681","volume":"9","author":"DB Hill","year":"2014","unstructured":"Hill DB, Vasquez PA, Mellnik J, McKinley SA, Vose A, Mu F, et al. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS ONE. 2014;9(2): e87681.","journal-title":"PLoS ONE"},{"issue":"4","key":"5286_CR96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ppul.10079","volume":"33","author":"M Robinson","year":"2002","unstructured":"Robinson M, Bye PTB. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol. 2002;33(4):293\u2013306.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"5286_CR97","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/JCI95693","volume":"128","author":"EM Dunican","year":"2018","unstructured":"Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Investig. 2018;128(3):997\u20131009.","journal-title":"J Clin Investig"},{"issue":"1","key":"5286_CR98","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12931-021-01759-z","volume":"22","author":"M Abdo","year":"2021","unstructured":"Abdo M, Uddin M, Goldmann T, Marwitz S, Bahmer T, Holz O, et al. Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma. Respir Res. 2021;22(1):167.","journal-title":"Respir Res"},{"issue":"10","key":"5286_CR99","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/cid\/ciaa508","volume":"71","author":"KE Hanson","year":"2020","unstructured":"Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, et al. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the idsa\u2019s diagnostics committee. Clin Infect Dis. 2020;71(10):2744\u201351.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5286_CR100","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1164\/rccm.201804-0734OC","volume":"199","author":"K Okuda","year":"2019","unstructured":"Okuda K, Chen G, Subramani DB, Wolf M, Gilmore RC, Kato T, et al. Localization of secretory mucins MUC5AC and MUC5B in normal\/Healthy human airways. Am J Respir Crit Care Med. 2019;199(6):715\u201327.","journal-title":"Am J Respir Crit Care Med"},{"key":"5286_CR101","doi-asserted-by":"publisher","DOI":"10.1242\/dev.177428","author":"S Ruiz Garc\u00eda","year":"2019","unstructured":"Ruiz Garc\u00eda S, Deprez M, Lebrigand K, Cavard A, Paquet A, Arguel MJ, et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development. 2019. https:\/\/doi.org\/10.1242\/dev.177428.","journal-title":"Development"},{"issue":"1","key":"5286_CR102","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11418-017-1144-z","volume":"72","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, et al. Enzyme-linked immunosorbent assay for the quantitative\/qualitative analysis of plant secondary metabolites. J Nat Med. 2018;72(1):32\u201342.","journal-title":"J Nat Med"},{"key":"5286_CR103","doi-asserted-by":"publisher","DOI":"10.3791\/54153","author":"KA Ramsey","year":"2016","unstructured":"Ramsey KA, Rushton ZL, Ehre C. Mucin agarose gel electrophoresis: western blotting for high-molecular-weight glycoproteins. J Visualized Exp. 2016. https:\/\/doi.org\/10.3791\/54153.","journal-title":"J Visualized Exp"},{"issue":"6","key":"5286_CR104","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/mi.2016.27","volume":"9","author":"G Radicioni","year":"2016","unstructured":"Radicioni G, Cao R, Carpenter J, Ford AA, Wang TT, Li Y, et al. The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome. Mucosal Immunol. 2016;9(6):1442\u201354.","journal-title":"Mucosal Immunol"},{"issue":"3","key":"5286_CR105","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI83922","volume":"126","author":"XX Tang","year":"2016","unstructured":"Tang XX, Ostedgaard LS, Hoegger MJ, Moninger TO, Karp PH, McMenimen JD, et al. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Investig. 2016;126(3):879\u201391.","journal-title":"J Clin Investig"},{"issue":"2","key":"5286_CR106","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.chest.2018.03.005","volume":"154","author":"JT Ma","year":"2018","unstructured":"Ma JT, Tang C, Kang L, Voynow JA, Rubin BK. Cystic fibrosis sputum rheology correlates with both acute and longitudinal changes in lung function. Chest. 2018;154(2):370\u20137.","journal-title":"Chest"},{"key":"5286_CR107","first-page":"7","volume":"15","author":"BN Porto","year":"2016","unstructured":"Porto BN, Stein RT. Neutrophil extracellular traps in pulmonary diseases: too much of a good thing? Front Immunol. 2016;15:7.","journal-title":"Front Immunol"},{"issue":"1","key":"5286_CR108","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1165\/rcmb.2020-0168OC","volume":"64","author":"RS Linssen","year":"2021","unstructured":"Linssen RS, Chai G, Ma J, Kummarapurugu AB, van Woensel JBM, Bem RA, et al. Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit. Am J Respir Cell Mol Biol. 2021;64(1):69\u201378.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"5286_CR109","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12931-019-1229-1","volume":"20","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zhong M, Luo Y, Deng L, Hu Z, Song Y. Determination of rheology and surface tension of airway surface liquid: a review of clinical relevance and measurement techniques. Respir Res. 2019;20(1):274.","journal-title":"Respir Res"},{"key":"5286_CR110","doi-asserted-by":"crossref","unstructured":"Esquinas AM. Humidification in the intensive care unit: The Essentials. 2nd ed. Vol. 1. Springer; 2024.","DOI":"10.1007\/978-3-031-23953-3"},{"issue":"3","key":"5286_CR111","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/bjaceaccp\/mku022","volume":"15","author":"G McNulty","year":"2015","unstructured":"McNulty G, Eyre L. Humidification in anaesthesia and critical care. BJA Educ. 2015;15(3):131\u20135.","journal-title":"BJA Educ"},{"key":"5286_CR112","doi-asserted-by":"crossref","unstructured":"American Association for Respiratory Care, Restrepo RD, Walsh BK. Humidification during invasive and noninvasive mechanical ventilation: 2012. Respir Care. 2012;57(5):782\u20138.","DOI":"10.4187\/respcare.01766"},{"key":"5286_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/medsci12020026","author":"R Re","year":"2024","unstructured":"Re R, Lassola S, De Rosa S, Bellani G. Humidification during Invasive and non-invasive ventilation: a starting tool kit for correct setting. Med Sci (Basel). 2024. https:\/\/doi.org\/10.3390\/medsci12020026.","journal-title":"Med Sci (Basel)."},{"issue":"Suppl 2","key":"5286_CR114","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-208209","volume":"71","author":"A Craig Davidson","year":"2016","unstructured":"Craig Davidson A, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, et al. BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2):ii1\u201335. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208209.","journal-title":"Thorax"},{"issue":"1","key":"5286_CR115","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2016-000170","volume":"4","author":"BR O\u2019Driscoll","year":"2017","unstructured":"O\u2019Driscoll BR, Howard LS, Earis J, Mak V. British thoracic society guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017;4(1): e000170.","journal-title":"BMJ Open Respir Res"},{"key":"5286_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1100\/2012\/465230","volume":"2012","author":"EP Reeves","year":"2012","unstructured":"Reeves EP, Molloy K, Pohl K, McElvaney NG. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. Scientific World Journal. 2012;2012:1\u201311.","journal-title":"Scientific World Journal"},{"issue":"3","key":"5286_CR117","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI83922","volume":"126","author":"XX Tang","year":"2016","unstructured":"Tang XX, Ostedgaard LS, Hoegger MJ, Moninger TO, Karp PH, McMenimen JD, et al. Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Investig. 2016;126(3):879\u201391.","journal-title":"J Clin Investig"},{"issue":"1_suppl","key":"5286_CR118","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1258\/JRSM.2011.S11101","volume":"104","author":"MR Elkins","year":"2011","unstructured":"Elkins MR, Bye PT. Mechanisms and applications of hypertonic saline. J Royal Society Med. 2011;104(1_suppl):2\u20135. https:\/\/doi.org\/10.1258\/JRSM.2011.S11101.","journal-title":"J Royal Society Med"},{"issue":"3","key":"5286_CR119","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa043891","volume":"354","author":"SH Donaldson","year":"2006","unstructured":"Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354(3):241\u201350.","journal-title":"N Engl J Med"},{"issue":"5","key":"5286_CR120","doi-asserted-by":"publisher","first-page":"1702652","DOI":"10.1183\/13993003.02652-2017","volume":"51","author":"JL Goralski","year":"2018","unstructured":"Goralski JL, Wu D, Thelin WR, Boucher RC, Button B. The in vitro effect of nebulised hypertonic saline on human bronchial epithelium. Eur Respir J. 2018;51(5):1702652.","journal-title":"Eur Respir J"},{"key":"5286_CR121","unstructured":"British National Formulary. Hypertonic Saline for Nebulisation [Internet]. [cited 2024 Apr 12]. Available from: https:\/\/bnf.nice.org.uk\/medical-devices\/nebuliser-solutions\/"},{"issue":"1","key":"5286_CR122","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1465-9921-11-119","volume":"11","author":"NS Gould","year":"2010","unstructured":"Gould NS, Gauthier S, Kariya CT, Min E, Huang J, Day BJ. Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury. Respir Res. 2010;11(1):119.","journal-title":"Respir Res"},{"issue":"4","key":"5286_CR123","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jcf.2007.11.009","volume":"7","author":"V Havasi","year":"2008","unstructured":"Havasi V, Hurst CO, Briles TC, Yang F, Bains DG, Hassett DJ, et al. Inhibitory effects of hypertonic saline on P. aeruginosa motility. J Cystic Fibrosis. 2008;7(4):267\u20139.","journal-title":"J Cystic Fibrosis"},{"issue":"4858","key":"5286_CR124","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/196988a0","volume":"196","author":"J Lieberman","year":"1962","unstructured":"Lieberman J, Kurnick NB. Influence of deoxyribonucleic acid content on the proteolysis of sputum and pus. Nature. 1962;196(4858):988\u201390.","journal-title":"Nature"},{"key":"5286_CR125","unstructured":"British National Formulary. National Institute of Health and Care Excellence. 2024 [cited 2025 Jan 13]. Nebuliser solutions. Available from: https:\/\/bnf.nice.org.uk\/medical-devices\/nebuliser-solutions\/"},{"issue":"12","key":"5286_CR126","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","volume":"105","author":"F Kellett","year":"2011","unstructured":"Kellett F, Robert NM. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir Med. 2011;105(12):1831\u20135.","journal-title":"Respir Med"},{"issue":"9290","key":"5286_CR127","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/S0140-6736(01)06412-1","volume":"358","author":"R Suri","year":"2001","unstructured":"Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, et al. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet. 2001;358(9290):1316\u201321.","journal-title":"Lancet"},{"issue":"5","key":"5286_CR128","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/tropej\/fms004","volume":"58","author":"S Gupta","year":"2012","unstructured":"Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized. Controlled Trial J Trop Pediatr. 2012;58(5):375\u201381.","journal-title":"Controlled Trial J Trop Pediatr"},{"issue":"10","key":"5286_CR129","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1164\/ajrccm.164.10.2104024","volume":"164","author":"C Taube","year":"2001","unstructured":"Taube C, Holz O, M\u00fccke M, J\u00f6rres RA, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(10):1810\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5286_CR130","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1442-200X.2011.03519.x","volume":"54","author":"H Altunhan","year":"2012","unstructured":"Altunhan H, Annag\u00fcr A, Pekcan S, \u00d6rs R, Ko\u00e7 H. Comparing the efficacy of nebulizer recombinant human DNase and hypertonic saline as monotherapy and combined treatment in the treatment of persistent atelectasis in mechanically ventilated newborns. Pediatr Int. 2012;54(1):131\u20136.","journal-title":"Pediatr Int"},{"issue":"6","key":"5286_CR131","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/jamp.2011.0954","volume":"25","author":"HA Youness","year":"2012","unstructured":"Youness HA, Mathews K, Elya MK, Kinasewitz GT, Keddissi JI. Dornase alpha compared to hypertonic saline for lung atelectasis in critically Ill patients. J Aerosol Med Pulm Drug Deliv. 2012;25(6):342\u20138.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"5286_CR132","unstructured":"Gupta R, Wadhwa R, StatPearls Mucolytic medications (2023)"},{"issue":"6","key":"5286_CR133","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/15412555.2014.898040","volume":"11","author":"P Santus","year":"2014","unstructured":"Santus P, Corsico A, Solidoro P, Braido F, Di Marco F, Scichilone N. Oxidative Stress and respiratory system: pharmacological and clinical reappraisal of N-Acetylcysteine. COPD: J Chronic Obstructive Pulm Dis. 2014;11(6):705\u201317. https:\/\/doi.org\/10.3109\/15412555.2014.898040.","journal-title":"COPD: J Chronic Obstructive Pulm Dis"},{"issue":"1","key":"5286_CR134","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","volume":"8","author":"MO Henke","year":"2007","unstructured":"Henke MO, Ratjen F. Mucolytics in cystic fibrosis. Paediatr Respir Rev. 2007;8(1):24\u20139.","journal-title":"Paediatr Respir Rev"},{"issue":"7","key":"5286_CR135","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/thx.49.7.670","volume":"49","author":"MM Bridgeman","year":"1994","unstructured":"Bridgeman MM, Marsden M, Selby C, Morrison D, MacNee W. Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax. 1994;49(7):670\u20135.","journal-title":"Thorax"},{"issue":"2","key":"5286_CR136","first-page":"73","volume":"70","author":"IA Cotgreave","year":"1987","unstructured":"Cotgreave IA, Eklund A, Larsson K, Mold\u00e9us PW. No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid. Eur J Respir Dis. 1987;70(2):73\u20137.","journal-title":"Eur J Respir Dis"},{"issue":"1","key":"5286_CR137","first-page":"21","volume":"4","author":"MC Atkinson","year":"2002","unstructured":"Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc. 2002;4(1):21\u20137.","journal-title":"Crit Care Resusc"},{"key":"5286_CR138","unstructured":"Drugs.com. Drugs.com. 2025 [cited 2025 Jan 13]. NAC Side Effects. Available from: https:\/\/www.drugs.com\/sfx\/nac-side-effects.html?form=inhalation_solution#"},{"issue":"2","key":"5286_CR139","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hrtlng.2018.09.010","volume":"48","author":"BJ Tarrant","year":"2019","unstructured":"Tarrant BJ, Le MC, Romero L, Steward R, Button BM, Thompson BR, et al. Mucoactive agents for adults with acute lung conditions: a systematic review. Heart Lung. 2019;48(2):141\u20137.","journal-title":"Heart Lung"},{"key":"5286_CR140","doi-asserted-by":"crossref","unstructured":"Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Database Syst Rev. 2013;2015(4).","DOI":"10.1002\/14651858.CD007168.pub3"},{"issue":"1","key":"5286_CR141","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2466-4-13","volume":"4","author":"PN Black","year":"2004","unstructured":"Black PN, Morgan-Day A, McMillan TE, Poole PJ, Young RP. Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med. 2004;4(1):13.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"5286_CR142","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4187\/respcare.04086","volume":"60","author":"NA Sathe","year":"2015","unstructured":"Sathe NA, Krishnaswami S, Andrews J, Ficzere C, McPheeters ML. Pharmacologic agents that promote airway clearance in hospitalized subjects: a systematic review. Respir Care. 2015;60(7):1061\u201370.","journal-title":"Respir Care"},{"issue":"4","key":"5286_CR143","first-page":"309","volume":"40","author":"SM Masoompour","year":"2015","unstructured":"Masoompour SM, Anushiravani A, Tafaroj NA. Evaluation of the effect of nebulized N-Acetylcysteine on respiratory secretions in mechanically ventilated patients: randomized clinical trial. Iran J Med Sci. 2015;40(4):309\u201315.","journal-title":"Iran J Med Sci"},{"issue":"3","key":"5286_CR144","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/JCMA.0000000000000869","volume":"86","author":"CH Chen","year":"2023","unstructured":"Chen CH, Hung KF, Huang CY, Leong JL, Chu YC, Chang CY, et al. Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis. J Chin Med Assoc. 2023;86(3):274\u201381.","journal-title":"J Chin Med Assoc"},{"key":"5286_CR145","unstructured":"Drugbank Online. Drugbank. [cited 2024 Apr 12]. Carbocisteine. Available from: https:\/\/go.drugbank.com\/drugs\/DB04339"},{"issue":"7","key":"5286_CR146","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1440-1843.2009.01594.x","volume":"14","author":"M Yoshida","year":"2009","unstructured":"Yoshida M, Nakayama K, Yasuda H, Kubo H, Kuwano K, Arai H, et al. Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells. Respirology. 2009;14(7):1027\u201334.","journal-title":"Respirology"},{"issue":"9","key":"5286_CR147","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1183\/09031936.94.07091622","volume":"7","author":"B Colombo","year":"1994","unstructured":"Colombo B, Turconi P, Daffonchio L, Fedele G, Omini C, Cremaschi D. Stimulation of Cl- secretion by the mucoactive drug S-carboxymethylcysteine-lysine salt in the isolated rabbit trachea. Eur Respir J. 1994;7(9):1622\u20138.","journal-title":"Eur Respir J"},{"issue":"6","key":"5286_CR148","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/pharmaceutics14061261","volume":"14","author":"E Pace","year":"2022","unstructured":"Pace E, Cerveri I, Lacedonia D, Paone G, Sanduzzi Zamparelli A, Sorbo R, et al. Clinical efficacy of carbocysteine in COPD: beyond the mucolytic action. Pharmaceutics. 2022;14(6):1261.","journal-title":"Pharmaceutics"},{"key":"5286_CR149","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/COPD.S140603","volume":"12","author":"Z Zeng","year":"2017","unstructured":"Zeng Z, Yang D, Huang X, Xiao Z. Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:2277\u201383.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9629","key":"5286_CR150","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","volume":"371","author":"JP Zheng","year":"2008","unstructured":"Zheng JP, Kang J, Huang SG, Chen P, Yao WZ, Yang L, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 2008;371(9629):2013\u20138.","journal-title":"Lancet"},{"issue":"1","key":"5286_CR151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1440-1843.2008.01424.x","volume":"14","author":"H Nogawa","year":"2009","unstructured":"Nogawa H, Ishibashi Y, Ogawa A, Masuda K, Tsubuki T, Kameda T, et al. Carbocisteine can scavenge reactive oxygen species in vitro. Respirology. 2009;14(1):53\u20139.","journal-title":"Respirology"},{"issue":"1\u20133","key":"5286_CR152","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejphar.2004.10.007","volume":"505","author":"GE Carpagnano","year":"2004","unstructured":"Carpagnano GE, Resta O, Foschino-Barbaro MP, Spanevello A, Stefano A, Di Gioia G, et al. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol. 2004;505(1\u20133):169\u201375.","journal-title":"Eur J Pharmacol"},{"key":"5286_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106190","volume":"175","author":"A Papi","year":"2020","unstructured":"Papi A, Avdeev S, Calverley PMA, Cordeiro CR, Jesenak M, Kobl\u00ed\u017eek V, et al. Use of mucolytics in COPD: a Delphi consensus study. Respir Med. 2020;175: 106190.","journal-title":"Respir Med"},{"key":"5286_CR154","doi-asserted-by":"crossref","unstructured":"Taggart C. ISRCTN Registry. 2023 [cited 2024 Apr 12]. To determine if critically ill patients with acute respiratory failure treated with carbocisteine, hypertonic saline, or both, experience increased hydration of airway mucus. Available from: https:\/\/www.isrctn.com\/ISRCTN10086050","DOI":"10.1186\/ISRCTN10086050"},{"key":"5286_CR155","unstructured":"MARCH Trial Team. NICTU. 2023 [cited 2024 Apr 12]. Mucoactives in Acute Respiratory failure: Carbocisteine and Hypertonic saline. Available from: https:\/\/nictu.hscni.net\/service\/march-trial\/"},{"key":"5286_CR156","doi-asserted-by":"crossref","unstructured":"Hao C, Xu H, Yu L, Zhang L. Heparin: An essential drug for modern medicine. In 2019;1\u201319.","DOI":"10.1016\/bs.pmbts.2019.02.002"},{"issue":"3","key":"5286_CR157","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/jappl.1992.73.3.1093","volume":"73","author":"J Lucio","year":"1992","unstructured":"Lucio J, D\u2019Brot J, Guo CB, Abraham WM, Lichtenstein LM, Kagey-Sobotka A, et al. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J Appl Physiol. 1992;73(3):1093\u2013101.","journal-title":"J Appl Physiol"},{"issue":"2","key":"5286_CR158","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jaci.2004.05.026","volume":"114","author":"D Zeng","year":"2004","unstructured":"Zeng D, Prosperini G, Russo C, Spicuzza L, Cacciola RR, Di Maria GU, et al. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation. J Allergy Clin Immunol. 2004;114(2):316\u201320.","journal-title":"J Allergy Clin Immunol"},{"issue":"3\u20134","key":"5286_CR159","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0049-3848(79)90097-5","volume":"16","author":"J Carr","year":"1979","unstructured":"Carr J. The anti-inflammatory action of heparin: Heparin as an antagonist to histamine, bradykinin and prostaglandin E1. Thromb Res. 1979;16(3\u20134):507\u201316.","journal-title":"Thromb Res"},{"issue":"16","key":"5286_CR160","doi-asserted-by":"publisher","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","volume":"261","author":"LB Schwartz","year":"1986","unstructured":"Schwartz LB, Bradford TR. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem. 1986;261(16):7372\u20139.","journal-title":"J Biol Chem."},{"issue":"37","key":"5286_CR161","doi-asserted-by":"publisher","first-page":"12187","DOI":"10.1021\/bi991046b","volume":"38","author":"G Pejler","year":"1999","unstructured":"Pejler G, Sadler JE. Mechanism by which heparin proteoglycan modulates mast cell chymase activity. Biochemistry. 1999;38(37):12187\u201395.","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"5286_CR162","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/pulp.1995.1012","volume":"8","author":"EAM Seeds","year":"1995","unstructured":"Seeds EAM, Horne AP, Tyrrell DJ, Page CP. The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs. Pulm Pharmacol. 1995;8(2\u20133):97\u2013105.","journal-title":"Pulm Pharmacol"},{"issue":"11","key":"5286_CR163","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/01.ATV.0000090671.56682.D7","volume":"23","author":"AA Khorana","year":"2003","unstructured":"Khorana AA, Sahni A, Altland OD, Francis CW. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight. Arterioscler Thromb Vasc Biol. 2003;23(11):2110\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"5286_CR164","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1111\/bcp.15212","volume":"88","author":"FMP van Haren","year":"2022","unstructured":"van Haren FMP, van Loon LM, Steins A, Smoot TL, Sas C, Staas S, et al. Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: a multicentre case series of 98 patients. Br J Clin Pharmacol. 2022;88(6):2802\u201313.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5286_CR165","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1378\/chest.123.4.1254","volume":"123","author":"AS Niven","year":"2003","unstructured":"Niven AS, Argyros G. Alternate treatments in asthma. Chest. 2003;123(4):1254\u201365.","journal-title":"Chest"},{"issue":"7","key":"5286_CR166","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.burns.2011.07.006","volume":"37","author":"LY Yip","year":"2011","unstructured":"Yip LY, Lim YF, Chan HN. Safety and potential anticoagulant effects of nebulised heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre. Burns. 2011;37(7):1154\u201360.","journal-title":"Burns"},{"issue":"5","key":"5286_CR167","doi-asserted-by":"publisher","first-page":"R180","DOI":"10.1186\/cc9286","volume":"14","author":"B Dixon","year":"2010","unstructured":"Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care. 2010;14(5):R180.","journal-title":"Crit Care"},{"issue":"4","key":"5286_CR168","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","volume":"9","author":"B Dixon","year":"2021","unstructured":"Dixon B, Smith RJ, Campbell DJ, Moran JL, Doig GS, Rechnitzer T, et al. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med. 2021;9(4):360\u201372.","journal-title":"Lancet Respir Med"},{"key":"5286_CR169","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li Q, Sun C, Gu Y, Qi Z, Li J. The effect of nebulized heparin on clinical outcomes in mechanically ventilated patients: a meta-analysis and review of the literature. J Int Med Res 2023;51(10).","DOI":"10.1177\/03000605231201340"},{"issue":"1","key":"5286_CR170","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13054-020-03148-2","volume":"24","author":"FMP van Haren","year":"2020","unstructured":"van Haren FMP, Page C, Laffey JG, Artigas A, Camprubi-Rimblas M, Nunes Q, et al. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care. 2020;24(1):454.","journal-title":"Crit Care"},{"issue":"8","key":"5286_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023710","volume":"6","author":"J Lang","year":"2011","unstructured":"Lang J, Yang N, Deng J, Liu K, Yang P, Zhang G, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE. 2011;6(8): e23710.","journal-title":"PLoS ONE"},{"issue":"8","key":"5286_CR172","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5005\/jp-journals-10071-24511","volume":"27","author":"B Gupta","year":"2023","unstructured":"Gupta B, Gupta A, Ahluwalia P, Gupta N. Role of nebulized heparin in clinical outcome of COVID-19 patients with respiratory symptoms: a systematic review. Indian J Critical Care Med. 2023;27(8):572\u20139.","journal-title":"Indian J Critical Care Med"},{"issue":"1","key":"5286_CR173","doi-asserted-by":"publisher","first-page":"13326","DOI":"10.1038\/s41598-023-40489-8","volume":"13","author":"R Ashmawy","year":"2023","unstructured":"Ashmawy R, Zaki A, Baess A, El Sayed I. Efficacy and safety of inhaled heparin in asthmatic and chronic obstructive pulmonary disease patients: a systematic review and a meta-analysis. Sci Rep. 2023;13(1):13326.","journal-title":"Sci Rep"},{"issue":"6","key":"5286_CR174","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","volume":"189","author":"MJ Kaplan","year":"2012","unstructured":"Kaplan MJ, Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. 2012;189(6):2689\u201395.","journal-title":"J Immunol"},{"key":"5286_CR175","doi-asserted-by":"crossref","unstructured":"Yang C, Montgomery M. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2018;9(9):CD001127.","DOI":"10.1002\/14651858.CD001127.pub4"},{"issue":"2","key":"5286_CR176","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/thx.33.2.235","volume":"33","author":"R Picot","year":"1978","unstructured":"Picot R, Das I, Reid L. Pus, deoxyribonucleic acid, and sputum viscosity. Thorax. 1978;33(2):235\u201342.","journal-title":"Thorax"},{"issue":"23","key":"5286_CR177","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","volume":"87","author":"S Shak","year":"1990","unstructured":"Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci. 1990;87(23):9188\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"5286_CR178","unstructured":"British National Formulary. Dornase-Alfa [Internet]. 2024 [cited 2024 Apr 12]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/dornase-alfa\/"},{"key":"5286_CR179","unstructured":"British National Formulary. National Institute for Health and Clinical Excellence. 2024 [cited 2025 Jan 13]. Dornase Alfa. Available from: https:\/\/bnf.nice.org.uk\/drugs\/dornase-alfa\/"},{"key":"5286_CR180","unstructured":"British National Formulary. National Institute for Health and Clinical Excellence. 2024 [cited 2025 Jan 13]. Cystic fibrosis: diagnosis and management. Available from: https:\/\/www.nice.org.uk\/guidance\/ng78"},{"key":"5286_CR181","doi-asserted-by":"crossref","unstructured":"Weber AG, Chau AS, Egeblad M, Barnes BJ, Janowitz T. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series. medRxiv. 2020","DOI":"10.1101\/2020.05.13.20087734"},{"key":"5286_CR182","first-page":"12","volume":"20","author":"ZM Holliday","year":"2021","unstructured":"Holliday ZM, Earhart AP, Alnijoumi MM, Krvavac A, Allen LAH, Schrum AG. Non-randomized trial of dornase alfa for acute respiratory distress syndrome secondary to Covid-19. Front Immunol. 2021;20:12.","journal-title":"Front Immunol"},{"issue":"2021","key":"5286_CR183","first-page":"1","volume":"23","author":"A Toma","year":"2021","unstructured":"Toma A, Darwish C, Taylor M, Harlacher J, Darwish R. The use of dornase alfa in the management of COVID-19-associated adult respiratory distress syndrome. Crit Care Res Pract. 2021;23(2021):1\u20136.","journal-title":"Crit Care Res Pract"},{"key":"5286_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100689","volume":"35","author":"AP Earhart","year":"2020","unstructured":"Earhart AP, Holliday ZM, Hofmann HV, Schrum AG. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome. New Microbes New Infect. 2020;35: 100689.","journal-title":"New Microbes New Infect"},{"key":"5286_CR185","first-page":"15","volume":"3","author":"A Kantar","year":"2020","unstructured":"Kantar A, Klimek L, Cazan D, Sperl A, Sent U, Mesquita M. Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety. Multidiscip Respir Med. 2020;3:15.","journal-title":"Multidiscip Respir Med"},{"key":"5286_CR186","first-page":"255","volume":"153","author":"BG Disse","year":"1987","unstructured":"Disse BG. The pharmacology of ambroxol\u2013review and new results. Eur J Respir Dis Suppl. 1987;153:255\u201362.","journal-title":"Eur J Respir Dis Suppl"},{"issue":"7","key":"5286_CR187","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-2000-4452","volume":"54","author":"HR Wirtz","year":"2000","unstructured":"Wirtz HR. Effekt von Ambroxol auf die Surfactantsekretion und -synthese von isolierten, alveol\u00e4ren Typ-II-Zellen. Pneumologie. 2000;54(7):278\u201383.","journal-title":"Pneumologie"},{"key":"5286_CR188","unstructured":"Drugs.com. Drugs.com. 2025 [cited 2025 Jan 13]. Ambroxol Hydrochloride. Available from: https:\/\/www.drugs.com\/ambroxol.html"},{"issue":"1","key":"5286_CR189","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000195270","volume":"51","author":"BG Disse","year":"1987","unstructured":"Disse BG, Ziegler HW. Pharmacodynamic mechanism and therapeutic activity of ambroxol in animal experiments. Respiration. 1987;51(1):15\u201322.","journal-title":"Respiration"},{"issue":"5","key":"5286_CR190","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1183\/09031936.02.00253302","volume":"19","author":"B Yang","year":"2002","unstructured":"Yang B, Yao DF, Ohuchi M, Ide M, Yano M, Okumura Y, et al. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. Eur Respir J. 2002;19(5):952\u20138.","journal-title":"Eur Respir J"},{"issue":"1","key":"5286_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-008-9142-8","volume":"57","author":"F Li","year":"2008","unstructured":"Li F, Yu J, Yang H, Wan Z, Bai D. Effects of ambroxol on alginate of mature pseudomonas aeruginosa biofilms. Curr Microbiol. 2008;57(1):1\u20137.","journal-title":"Curr Microbiol"},{"issue":"3","key":"5286_CR192","first-page":"317","volume":"45","author":"D Nowak","year":"1993","unstructured":"Nowak D, Pietras T, Antczak A, Kr\u00f3l M, Piasecka G. Ambroxol inhibits endotoxin-induced lipid peroxidation in mice. Pol J Pharmacol. 1993;45(3):317\u201322.","journal-title":"Pol J Pharmacol"},{"issue":"1","key":"5286_CR193","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00134-003-2001-y","volume":"30","author":"X Su","year":"2004","unstructured":"Su X, Wang L, Song Y, Bai C. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med. 2004;30(1):133\u201340.","journal-title":"Intensive Care Med"},{"issue":"8","key":"5286_CR194","first-page":"967","volume":"37","author":"R Gen\u00e9","year":"1987","unstructured":"Gen\u00e9 R, Poderoso JJ, Corazza C, Lasala MB, Wiemeyer JC, Fern\u00e1ndez M, et al. Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid. Arzneimittelforschung. 1987;37(8):967\u20138.","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"5286_CR195","first-page":"965","volume":"37","author":"J Sp\u00e1tola","year":"1987","unstructured":"Sp\u00e1tola J, Poderoso JJ, Wiemeyer JC, Fern\u00e1ndez M, Guerreiro RB, Corazza C. Influence of ambroxol on lung tissue penetration of amoxicillin. Arzneimittelforschung. 1987;37(8):965\u20136.","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"5286_CR196","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","volume":"4","author":"M Malerba","year":"2008","unstructured":"Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008;4(8):1119\u201329.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"5286_CR197","first-page":"849","volume":"39","author":"Y Gao","year":"2014","unstructured":"Gao Y, Cheng Y, Dong S, He Z, Zhou W, Liang L, et al. Effect of perioperative treatment with ambroxol on lung cancer patients after video-assisted thoracic surgery lobectomy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(8):849\u201354.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"11","key":"5286_CR198","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jcph.389","volume":"54","author":"X Wu","year":"2014","unstructured":"Wu X, Li S, Zhang J, Zhang Y, Han L, Deng Q, et al. Meta-analysis of high doses of ambroxol treatment for acute lung injury\/acute respiratory distress syndrome based on randomized controlled trials. J Clin Pharmacol. 2014;54(11):1199\u2013206.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"5286_CR199","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/app14020693","volume":"14","author":"T Talbot","year":"2024","unstructured":"Talbot T, Roe T, Dushianthan A. Management of acute life-threatening asthma exacerbations in the intensive care unit. Appl Sci. 2024;14(2):693.","journal-title":"Appl Sci"},{"issue":"02","key":"5286_CR200","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2005-869541","volume":"26","author":"MM Weder","year":"2005","unstructured":"Weder MM, Donohue JF. Role of bronchodilators in chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005;26(02):221\u201334.","journal-title":"Semin Respir Crit Care Med"},{"issue":"164","key":"5286_CR201","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0196-2021","volume":"31","author":"L Calzetta","year":"2022","unstructured":"Calzetta L, Ritondo BL, Zappa MC, Manzetti GM, Perduno A, Shute J, et al. The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. Eur Respir Rev. 2022;31(164): 210196.","journal-title":"Eur Respir Rev"},{"issue":"5","key":"5286_CR202","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1378\/chest.128.5.3743","volume":"128","author":"JR Sabater","year":"2005","unstructured":"Sabater JR, Lee TA, Abraham WM. Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep. Chest. 2005;128(5):3743\u20139.","journal-title":"Chest"},{"issue":"6","key":"5286_CR203","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1152\/japplphysiol.00755.2001","volume":"92","author":"JI Frohock","year":"2002","unstructured":"Frohock JI, Wijkstrom-Frei C, Salathe M. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells. J Appl Physiol. 2002;92(6):2396\u2013402.","journal-title":"J Appl Physiol"},{"issue":"2","key":"5286_CR204","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1152\/jappl.1988.65.2.971","volume":"65","author":"LB Wong","year":"1988","unstructured":"Wong LB, Miller IF, Yeates DB. Stimulation of ciliary beat frequency by autonomic agonists: in vivo. J Appl Physiol. 1988;65(2):971\u201381.","journal-title":"J Appl Physiol"},{"issue":"3","key":"5286_CR205","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1378\/chest.103.3.805","volume":"103","author":"J Mortensen","year":"1993","unstructured":"Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. Reduced effect of inhaled \u03b22-Adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest. 1993;103(3):805\u201311.","journal-title":"Chest"},{"issue":"1","key":"5286_CR206","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1378\/chest.129.1.124","volume":"129","author":"TG O\u2019Riordan","year":"2006","unstructured":"O\u2019Riordan TG, Mao W, Palmer LB, Chen JJ. Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients. Chest. 2006;129(1):124\u201332.","journal-title":"Chest"},{"issue":"9","key":"5286_CR207","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.4187\/respcare.10628","volume":"68","author":"W Stilma","year":"2023","unstructured":"Stilma W, Lilien TA, Bos LD, Saatpoor A, Elsayed O, Paulus F, et al. Airway mucus in invasively ventilated critically Ill patients. Respir Care. 2023;68(9):1258\u201361.","journal-title":"Respir Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05286-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05286-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:52:30Z","timestamp":1738918350000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05286-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5286"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05286-x","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable in this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}